Studies Enabled

The ACP Repository was developed to provide a much needed resource to the research community—high-quality samples and associated data from study participants with MS and selected other demyelinating diseases, and their affected and unaffected relatives and unrelated matched controls.

Since the launch of the repository, we have approved 63 requests for samples and data, 40 of which have come from academic/nonprofit institutions and the other 23 from industry research groups. Samples and data are available to researchers studying the causes of MS and related diseases.

 

Organizations using the ACP Repository for their research
  • 23andMe
  • Montreal Neurological Institute
  • St. Vincent's Hospital
  • Athabasca University
  • MSDx , LLC
  • Stanford
  • Beth Israel Deaconess Medical Center
  • NASA
  • SUNY Upstate Medical University
  • Biodesix
  • Ohio State University
  • SUNY Upstate Medical University
  • Biogen Idec
  • Oklahoma Medical Research Foundation
  • University of California Irvine
  • Brigham & Women’s Hospital
  • Pfizer
  • University of California San Francisco
  • DioGenix
  • Protagen AG
  • University of Maryland
  • Genelogic
  • Questcor
  • University of Michigan
  • GeNeuro SA
  • Regeneron
  • University of Texas Southwestern
  • Glycominds Ltd.
  • Science Commons
  • Vaccinex
  • Harvard School of Public Health
  • Scripps Research Institute
  • Vanderbilt
  • Johns Hopkins University
  • SomaLogic
  • Wellcome Trust Project
  • Knowledge Visualization Systems
  • Spectrum Health
 
  • Mayo Clinic
  • St. George's University of London
 

 

  • St. John's University
 

 

Examples of disorders studied
  • Multiple Sclerosis (MS)
  • Acute Disseminated Encephalomyelitis (ADEM)
  • Neuromyelitis Optica (NMO)
     
  • Clinically Isolated Syndrome (CIS)
  • Relapsing Remitting MS (RRMS)
  • Optic Neuritis (ON)
  • Secondary Progressive MS (SPMS)
  • Transverse Myelitis (TM)
  • Primary Progressive MS (PPMS)
 

 

Key topics of study
  • Data visualization
  • Immunology
  • Treatments and Therapeutics
  • Diagnostics
  • Risk Factors
 
  • Genetics

     
   

 

Key biological targets, genes, etc.
  • AQP-4
  • Glycosylation pathway
  • pNF-H
  • Blood brain barrier
  • MSRV
  • PrP
  • CD24
  • NMO-IgG
  • SHP-1
  • Epstein-Barr virus
  • Mycobacterium avium
  • Visfatin
  • EBNA-1
  • Myelin basic protein
 

 

Share